Inventor · disambiguated record
Paul Habermann
Also filed as: HABERMANN PAUL
34 granted patents·13 pending applications·822 citations·filing 1989–2024
98Inventor score
Top patents by PatentIndex Score
47 records- 0196US6221633B1Insulin derivatives having a rapid onset of actionAVENTIS PHARMA GMBH·Filed 1998·Granted Apr 24, 2001·193 cites·64 claims
- 0295US8048854B2Amidated insulin glargineSANOFI AVENTIS DEUTSCHLAND·Filed 2009·Granted Nov 1, 2011·33 cites·8 claims
- 0389US7939293B2Method for producing carboxy-terminal-amidified peptidesSANOFI AVENTIS DEUTSCHLAND·Filed 2005·Granted May 10, 2011·26 cites·26 claims
- 0488US5359035ABifunctional proteins including interleukin-2 (IL-2) and granuloctyte macrophage colony stimulating factor (GM-CSF)HOECHST AG·Filed 1992·Granted Oct 25, 1994·108 cites·14 claims
- 0588US5358857AMethod of preparing fusion proteinsGEN HOSPITAL CORP·Filed 1993·Granted Oct 25, 1994·75 cites·12 claims
- 0687US8633156B2Insulin derivatives having an extremely delayed time-action profileHABERMANN PAUL·Filed 2010·Granted Jan 21, 2014·18 cites·27 claims
- 0786US7202059B2Fusion proteins capable of being secreted into a fermentation mediumWACKER CHEMIE GMBH·Filed 2002·Granted Apr 10, 2007·16 cites·18 claims
- 0886US5227293AFusion proteins, their preparation and useGEN HOSPITAL CORP·Filed 1992·Granted Jul 13, 1993·71 cites·17 claims
- 0985US6534288B1C peptide for improved preparation of insulin and insulin analogsAVENTIS PHARMA GMBH·Filed 2000·Granted Mar 18, 2003·12 cites·14 claims
- 1083US11230582B2FGF21 variantsSANOFI SA·Filed 2016·Granted Jan 25, 2022·2 cites·6 claims
- 1179US6221837B1Insulin derivatives with increased zinc bindingAVENTIS PHARMA GMBH·Filed 1997·Granted Apr 24, 2001·45 cites·22 claims
- 1278US6875589B1Mini-proinsulin, its preparation and useHOECHST AG·Filed 1995·Granted Apr 5, 2005·32 cites·10 claims
- 1378US5496924AFusion protein comprising an interleukin-2 fragment ballast portionHOECHST AG·Filed 1992·Granted Mar 5, 1996·45 cites·10 claims
- 1477US2025171512A1Fgf21 variantsSANOFI SA·Filed 2024·Application pending·0 cites
- 1574US6531294B1Preparation of pancreatic procarboxypeptidase B, isoforms and muteins thereof and their useAVENTIS PHARMA GMBH·Filed 2000·Granted Mar 11, 2003·3 cites·1 claims
- 1672US7455987B1Signal sequences for preparing leu-hirudin by secretion by E. coli into the culture mediumSANOFI AVENTIS DEUTSCHLAND·Filed 2000·Granted Nov 25, 2008·6 cites·4 claims
- 1766US2022227825A1Fgf21 variantsSANOFI SA·Filed 2021·Application pending·0 cites
- 1865US5180668AHirudin derivativeHOECHST AG·Filed 1989·Granted Jan 19, 1993·11 cites·6 claims
- 1964US5866371AProcess for using the yeast ADH II promoter system for the production of heterologous proteins in high yieldsHOECHST AG·Filed 1996·Granted Feb 2, 1999·18 cites·16 claims
- 2062US6686177B1Insulin analogs with enhanced zinc bindingAVENTIS PHARMA GMBH·Filed 1999·Granted Feb 3, 2004·21 cites·44 claims
- 2162US6514730B1Secretion of hirudin derivativesCONSORTIUM ELEKTROCHEM IND·Filed 1999·Granted Feb 4, 2003·12 cites·15 claims
- 2262US5093322ATick-derived amblyommin and method of antithrombin therapyHOECHST AG·Filed 1989·Granted Mar 3, 1992·11 cites·7 claims
- 2360US5095092AProcess for the isolation and purification of hirudinHOECHST AG·Filed 1990·Granted Mar 10, 1992·19 cites·6 claims
- 2458US5919895ASecretion of hirudin derivativesCONSORTIUM ELEKTROCHEM IND·Filed 1992·Granted Jul 6, 1999·12 cites·6 claims
- 2556US2018236033A1Pharmaceutical composition for treating a metabolic syndromeSANOFI SA·Filed 2018·Application pending·0 cites
- 2653US2019085043A1Fusion proteins for treating a metabolic syndromeSANOFI SA·Filed 2018·Application pending·0 cites
- 2751US5538946AHirudin derivatives with delayed actionHOECHST AG·Filed 1992·Granted Jul 23, 1996·8 cites·10 claims
- 2851US2014073563A1Fusion proteins for treating a metabolic syndromeBOSCHEINEN OLIVER·Filed 2013·Application pending·0 cites
- 2950US2016279199A1Pharmaceutical composition for treating a metabolic syndromeSANOFI SA·Filed 2016·Application pending·0 cites
- 3049US8410048B2Method for producing insulin analogs having a dibasic B chain terminusHABERMANN PAUL·Filed 2009·Granted Apr 2, 2013·0 cites·21 claims
- 3149US7638618B2Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interestSANOFI AVENTIS DEUTSCHLAND·Filed 2002·Granted Dec 29, 2009·0 cites·9 claims
- 3249US2013203651A1Pharmaceutical composition for treating a metabolic syndromeSOMMERFELD MARK·Filed 2011·Application pending·0 cites
- 3348US2003176673A1Nucleic acids, proteins, and processes thereof such as use of fusion proteins whose N-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeastsFiled 2002·Application pending·0 cites
- 3447US5298603AGM-CSF protein, its derivatives, the preparation of proteins of this type, and their useHOECHST AG·Filed 1992·Granted Mar 29, 1994·8 cites·1 claims
- 3547US2015231210A1Pharmaceutical Composition for Treating a Metabolic SyndromeSANOFI SA·Filed 2015·Application pending·0 cites
- 3646US10660852B2Expression and folding in the manufacturing process of CD-RAP by using a CD-RAP precursor proteinBIONET PHARMA GMBH·Filed 2016·Granted May 26, 2020·0 cites·13 claims
- 3746US2016194371A1Fusion proteins comprising FGF-21 and GLP-1R agonistSANOFI SA·Filed 2015·Application pending·0 cites
- 3846US2002173620A1Bifunctional fusion proteins formed from hirudin and TAPFiled 2001·Application pending·0 cites
- 3945US8765910B2Method for amidating polypeptides with basic amino acid C-terminals by means of specific endoproteasesRISSOM SEBASTIAN·Filed 2006·Granted Jul 1, 2014·0 cites·5 claims
- 4045US5316947ASynthetic isohirudins with improved stabilityHOECHST AG·Filed 1993·Granted May 31, 1994·4 cites·2 claims
- 4145US5286714ASynthetic isohirudins with improved stabilityHOECHST AG·Filed 1992·Granted Feb 15, 1994·4 cites·9 claims
- 4244US2020268663A1Expression and folding in the manufacturing process of cd-rap by using a cd-rap precursor proteinBIONET PHARMA GMBH·Filed 2020·Application pending·0 cites
- 4342US5322926AIsohirudinsHOECHST AG·Filed 1993·Granted Jun 21, 1994·5 cites·12 claims
- 4438US5616476ASynthetic isohirudins with improved stabilityHOECHST AG·Filed 1995·Granted Apr 1, 1997·3 cites·2 claims
- 4537US2014142023A1Pharmaceutical Composition for Treating A Metabolic SyndromeSOMMERFELD MARK·Filed 2012·Application pending·0 cites
- 4635US9644017B2Insulin derivatives having an extremely delayed time-action profileHABERMANN PAUL·Filed 2010·Granted May 9, 2017·0 cites·37 claims
- 4734US5866399AProcess for inactivating carboxypeptidase Y in hirudin-containing culture brothsHOECHST AG·Filed 1996·Granted Feb 2, 1999·1 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Paul Habermann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →